Trends & Ideas: Stocking Up For The Diabetes Epidemic

SP Capital IQ  |

S&P Capital IQ Equity Analyst Herman Saftlas joins Brian Egli, S&P Capital IQ Editorial, to discuss diabetes and where investment opportunities might lie with companies that are fighting this disease such as Johnson & Johnson (JNJ) . To read this and all Trends & Ideas content, please visit www.marketscope.com.

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
JNJ Johnson & Johnson 138.44 1.27 0.93 5,882,503 Trade
SGGHD Signature Group Hldgs New n/a n/a n/a 0

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Blockchain in Digital Identity - Discussion at the EU Parliament

From the recent Blockchain For Europe Summit in Brussels: Panel on Digital Identity